Search Results - "Auteri, A."

Refine Results
  1. 1
  2. 2

    Long-term plasma levels of leptin and adiponectin in Rett syndrome by Blardi, P., De Lalla, A., D'Ambrogio, T., Vonella, G., Ceccatelli, L., Auteri, A., Hayek, J.

    Published in Clinical endocrinology (Oxford) (01-05-2009)
    “…Summary Objective  Rett syndrome is a progressive neurological disorder affecting almost exclusively females after age 6 months and characterised by acquired…”
    Get full text
    Journal Article
  3. 3

    Time-dependent effect of statins on platelet function in hypercholesterolaemia by Puccetti, L., Pasqui, A. L., Pastorelli, M., Bova, G., Cercignani, M., Palazzuoli, A., Angori, P., Auteri, A., Bruni, F.

    Published in European journal of clinical investigation (01-12-2002)
    “…Background Reduction of platelet activity induced by statins has been described as a positive effect exerted by such molecules on vascular thrombotic events…”
    Get full text
    Journal Article
  4. 4

    Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients by Di Renzo, M, Sbano, P, De Aloe, G, Pasqui, A.L, Rubegni, P, Ghezzi, A, Auteri, A, Fimiani, M

    Published in Clinical and experimental immunology (01-03-2008)
    “…Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation. Extracorporeal photochemotherapy (ECP) has been introduced…”
    Get full text
    Journal Article
  5. 5

    Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients by Puccetti, L., Sawamura, T., Pasqui, A. L., Pastorelli, M., Auteri, A., Bruni, F.

    Published in European journal of clinical investigation (01-01-2005)
    “…Background  Oxidized‐LDL (ox‐LDL) are proatherogenic and platelet‐activating molecules. Atorvastatin reduces platelet activity before cholesterol‐lowering…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Rett Syndrome and Plasma Leptin Levels by Blardi, P., MD, de Lalla, A., PhD, D’Ambrogio, T., MD, Zappella, M., MD, Cevenini, G., PhD, Ceccatelli, L., Biol D, Auteri, A., MD, Hayek, J., MD

    Published in The Journal of pediatrics (2007)
    “…Objective To describe in patients with Rett syndrome (classic and preserved-speech variant) plasma leptin levels and their relationship to BMI (body mass…”
    Get full text
    Journal Article
  8. 8

    Common variable immunodeficiency: a review by Di Renzo, M, Pasqui, A L, Auteri, A

    Published in Clinical and experimental medicine (01-04-2004)
    “…Common variable immunodeficiency (CVID) is the commonest symptomatic primary antibody deficiency syndrome. The predominant manifestation is…”
    Get full text
    Journal Article
  9. 9

    Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects by Bruni, F., Pasqui, A.L., Pastorelli, M., Bova, G., Di Renzo, M., Cercigani, M., Leo, A., Auteri, A., Puccetti, L.

    Published in International journal of cardiology (01-06-2004)
    “…Background: Hydroxymethyl-glutaryl-CoA-reductase inhibitors (statins) reduce cardiovascular events by cholesterol lowering as well as non-lipid related…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes by Pasqui, A L, Di Renzo, M, Bova, G, Maffei, S, Pompella, G, Auteri, A, Puccetti, L

    Published in Clinical and experimental medicine (01-03-2006)
    “…The aim of this study was to evaluate the presence of an imbalance between proinflammatory and anti-inflammatory mediators in patients affected by acute…”
    Get full text
    Journal Article
  12. 12

    Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia by Puccetti, L., Bruni, F., Pasqui, A. L., Pastorelli, M., Ciani, F., Palazzuoli, A., Acampa, M., Auteri, A.

    Published in European journal of clinical investigation (01-01-2008)
    “…ABSTRACT Background  Recent data indicate that statins could offer coronary artery disease (CAD) benefit even by mechanisms beyond lipid lowering. Genetic…”
    Get full text
    Journal Article
  13. 13

    Cytokines in acute coronary syndromes by Pasqui, A.L., Di Renzo, M., Auteri, A., Puccetti, L.

    Published in International journal of cardiology (07-12-2005)
    “…The aim of this study was to show the presence of an imbalance between pro-inflammatory and anti-inflammatory mediators in patients affected by acute coronary…”
    Get full text
    Journal Article
  14. 14

    Structural and functional abnormality of systemic microvessels in cardiac syndrome X by Pasqui, A.L., Puccetti, L., Di Renzo, M., Bruni, F., Camarri, A., Palazzuoli, A., Biagi, F., Servi, M., Bischeri, D., Auteri, A., Pastorelli, M.

    “…Microvascular damage of coronary bed has been considered the main pathogenetic factor of cardiac syndrome X (chest pain, exercise-induced ischemic ST-segment…”
    Get full text
    Journal Article
  15. 15

    Increased TNF-α production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine by Pasqui, A. L., Di Renzo, M., Auteri, A., Federico, G., Puccetti, L.

    Published in European journal of clinical investigation (01-09-2007)
    “…Background  Inflammatory and/or immune activation occurs both in animal models (twitcher mice) and in the brain of patients with Globoid cell leukodystrophy…”
    Get full text
    Journal Article
  16. 16

    Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment by Puccetti, L, Pasqui, A.L, Bruni, F, Pastorelli, M, Ciani, F, Palazzuoli, A, Pontani, A, Ghezzi, A, Auteri, A

    Published in International journal of cardiology (25-06-2007)
    “…Abstract Background Oxidized-LDL (ox-LDL) are involved in atherothrombosis by induction of endothelial dysfunction and thrombosis. The specific receptor…”
    Get full text
    Journal Article
  17. 17

    Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease by Renzo, M. Di, Rubegni, P., Pasqui, A.L., Pompella, G., Aloe, G. De, Sbano, P., Cuccia, A., Castagnini, C., Auteri, A., Laghi Pasini, F., Fimiani, M.

    Published in British journal of dermatology (1951) (01-07-2005)
    “…Summary Background  Chronic graft‐versus‐host disease (cGVHD) is a major complication of allogeneic bone marrow transplantation. Extracorporeal photopheresis…”
    Get full text
    Journal Article
  18. 18

    ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY by E. Malacco, S. Omboni, M. Volpe, A. Auteri, A. Zanchetti

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-02-2012)
    “…Objective. To compare the efficacy and safety of the angiotensin II antagonist olmesartan medoxomil (O) and the ACE inhibitor ramipril (R) in elderly patients…”
    Get full text
    Journal Article
  19. 19

    Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure by Palazzuoli, A., Bruni, F., Puccetti, L., Pastorelli, M., Angori, P., Pasqui, A.L., Auteri, A.

    Published in European journal of heart failure (01-12-2002)
    “…Background: Recent studies have shown that carvedilol therapy in patients with heart failure improves clinical outcome and survival, however, the effects of…”
    Get full text
    Journal Article
  20. 20

    Nimodipine: Drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia by Blardi, Patrizia, Urso, Renato, Lalla, Arianna, Volpi, Luciana, Perri, Tullio Di, Auteri, Alberto

    Published in Clinical pharmacology and therapeutics (01-11-2002)
    “…Background and Objective Nimodipine is a dihydropyridine calcium channel blocker used in the treatment of ischemic damage in subarachnoid hemorrhage. Recent…”
    Get full text
    Journal Article